Aggredyne

About:

Aggredyne is a biomedical company developing diagnostic devices for platelet therapy.

Description:

Aggredyne, Inc. (www.aggredyne.com), is a biomedical company founded in 2011 by Edward R. Teitel, MD, JD, and Robert C. Hux, CPA, to commercialize the AggreGuideTM platelet function analyzer. The AggreGuide system is an in-vitro diagnostic test that measures how sticky a patient’s platelets are and how well the patient is responding to antiplatelet medications such as aspirin or Plavix® (clopidogrel), Effient® (prasugrel) and Brillinta® (ticagrelor).

Total Funding Amount:

$3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2011-01-01

Founders:

Edward R. Teitel, Robert C. Hux

Number of Employees:

51-100

Last Funding Date:

2012-04-23

IPO Status:

Private

Industries: